RDY

Q: What is the price of Dr. Reddy's Laboratories (RDY) today?

The current price of Dr. Reddy's Laboratories (RDY) is $ 13.26, representing a -14.34% gain over the past year. The stock began the year trading around $ 14.04 and is currently priced at $ 13.26. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Dr. Reddy's Laboratories (RDY) pay dividends?

Dr. Reddy's Laboratories (RDY) did not pay dividends over the past year.

Dr. Reddy's Laboratories Ltd.

Price

$ 13.26

return (12m)

-14.34%

p/e

22.75

p/bv

2.70

DIVIDEND YIELD

0.54%

RDY price

Dr. Reddy's Laboratories

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RDY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.38%

3 months

-7.95%

1 year

-14.34%

2 years

-6.11%

5 years

-5.32%

10 years

54.54%

Fundamentals RDY

review the fundamentals of Dr. Reddy's Laboratories shares

P/E

22.75

Sector: -1.72 Industry: -5.50

P/S (PSR)

2.93

Sector: 1.97 Industry: 2.98

P/BV

2.70

Sector: 2.13 Industry: 1.95

DIVIDEND YIELD (DY)

0.54%

Sector: - Industry: -

ROA

7.79%

Sector: -27.63% Industry: -50.45%

ROE

11.86%

Sector: -33.26% Industry: -47.51%

ROIC

0.81%

Sector: -439.47% Industry: -539.51%

NET MARGIN

12.89%

Sector: -29.66% Industry: -36.80%

GROSS MARGIN

55.55%

Sector: 45.32% Industry: 49.57%

OPERATING MARGIN

15.02%

Sector: -24.55% Industry: -32.48%

EV/EBITDA

12.35

Sector: -0.34 Industry: -3.00

EV/EBIT

16.64

Sector: -1.74 Industry: -5.20

PRICE-TO-ASSETS

1.77

Sector: 1.17 Industry: 1.27

BVPS

4.91

Sector: 3.91 Industry: 2.03

EPS

0.58

Sector: -0.90 Industry: -1.30

EQUITY-TO-ASSETS RATIO

0.66

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.34

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

6.09%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

6.44%

Sector: - Industry: -

FAIR VALUE OF Dr. Reddy's Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 13.26

Fair Value

$ 8.00

Upside Return potential.

-39.61%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RDY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	39.95	32.37	81.02%	0.55%	$ 1.01 T	34.99%
ISRG	50.29	8.51	16.93%	0.00%	$ 149.83 B	28.15%
SNY	7.36	1.31	17.79%	8.84%	$ 109.89 B	14.75%
TMO	25.68	3.38	13.15%	0.37%	$ 175.88 B	15.15%
NVS	21.04	7.31	34.77%	2.08%	$ 284.75 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	22.71	2.13	9.38%	3.48%	$ 104.78 B	13.00%
GSK	13.10	4.42	33.77%	3.43%	$ 102.78 B	17.79%
CVS	41.65	1.57	3.78%	2.77%	$ 122.12 B	0.72%
BSX	20.36	2.81	13.78%	0.00%	$ 72.58 B	17.29%
TMDX	13.73	4.78	34.80%	0.00%	$ 2.36 B	27.04%
HCA	12.27	-27.99	-228.14%	0.79%	$ 83.36 B	8.89%
IDXX	41.06	28.90	70.38%	0.00%	$ 44.97 B	24.63%
RMD	18.65	4.37	23.41%	1.19%	$ 28.34 B	27.44%
DHR	35.37	2.46	6.97%	0.74%	$ 130.48 B	14.89%
INMD	9.78	1.29	13.18%	0.00%	$ 853.02 M	23.27%
PHG	22.01	1.88	8.56%	3.88%	$ 24.87 B	5.50%
SYK	34.98	5.08	14.52%	1.13%	$ 116.73 B	13.21%
CI	11.78	1.81	15.39%	2.10%	$ 76.49 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RDY Historical Dividends

current DY: 0.54%

5-year average DY: 0.62%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/09/2025	08/06/2025	0,07150000
Dividends	07/12/2024	08/12/2024	0,09524000
Dividends	07/06/2023	08/11/2023	0,09652000
Dividends	07/07/2022	08/12/2022	0,07568000
Dividends	07/07/2021	08/11/2021	0,06840000
Dividends	07/09/2020	08/17/2020	0,06668000
Dividends	07/11/2019	08/15/2019	0,05644000
Dividends	07/12/2018	08/09/2018	0,05840000
Dividends	07/13/2017	08/10/2017	0,06278000
Dividends	07/14/2016	08/09/2016	0,05990000
Dividends	07/08/2015	08/17/2015	0,06258000
Dividends	07/09/2014	08/15/2014	0,06060000
Dividends	07/10/2013	08/15/2013	0,05280000
Dividends	06/27/2012	08/06/2012	0,04580000
Dividends	06/29/2011	08/11/2011	0,05092000
Dividends	06/14/2011	06/23/2011	0,13206000
Dividends	06/30/2010	08/17/2010	0,04826000
Dividends	07/03/2009	08/12/2009	0,02608000
Dividends	07/04/2008	08/18/2008	0,01776000
Dividends	07/06/2007	08/10/2007	0,01858000
Dividends	07/07/2006	08/21/2006	0,01072000
Dividends	07/07/2005	08/16/2005	0,01148000
Dividends	07/15/2004	08/24/2004	0,01076000
Dividends	08/07/2003	10/02/2003	0,01092000
Dividends	08/08/2002	09/30/2002	0,00510000
Dividends	11/21/2001	12/13/2001	0,01042000

ABOUT Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd.

Average Investor10 user rating

4.0 (3 people)

United States

42 years

Founded: 1984

2001

Time since IPO - 25 years

22.740

Employees

Dr. Reddy's Laboratories Ltd. (United States) is listed on the NYSE and has a market capitalization of $11.05 Billions, with shareholders equity totaling $4.10 Billions.

The company employs approximately 22.740 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Dr. Reddy's Laboratories Ltd. reported $3.77 Billions in revenue, generating net income of $485.99 Millions.

Key financial metrics include a P/E ratio of 22.75, a price-to-book (P/B) ratio of 2.70, and a trailing twelve-month dividend yield of 0.54%.

The company trades under the ticker RDY.

Market cap

$ 11.05 Billions

Net worth

$ 4.10 Billions

$ 4,098,950,000.00

Assets

$ 6.24 Billions

$ 6,241,730,000.00

Total Shares Outstanding

834.00 Millions

834,000,000

Average Daily Trading Volume

$ 2.48 Millions

$ 2,479,822.00

Sector

Health

Industry

Pharmaceutical Products

RDY

RDY revenue and profits

Financial Results RDY

DRAG THE FRAME TO SEE MORE DATA

RDY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 95.93 56,38% (12M)

P/E

41.65

2.77%

ROE

3.78%

P/BV

1.57

CI - Cigna

$ 289.48 --5,32% (12M)

P/E

11.78

2.10%

ROE

15.39%

P/BV

1.81

CNC - Centene

$ 62.33 13,00% (12M)

P/E

-4.76

0.00%

ROE

-29.93%

P/BV

1.42

HUM - Humana

$ 350.08 54,13% (12M)

P/E

37.18

1.01%

ROE

6.06%

P/BV

2.25

SNY - Sanofi

$ 45.02 --3,18% (12M)

P/E

7.36

8.84%

ROE

17.79%

P/BV

1.31

LLY - Eli Lilly

$ 1,131.42 47,32% (12M)

P/E

39.95

0.55%

ROE

81.02%

P/BV

32.37

HCA - HCA Healthcare

$ 372.13 --2,35% (12M)

P/E

12.27

0.79%

ROE

-228.14%

P/BV

-27.99

NVS - Novartis

$ 149.16 28,84% (12M)

P/E

21.04

2.08%

ROE

34.77%

P/BV

7.31

CVS - CVS Health

$ 95.93 56,38% (12 M)

P/L

41.65

2.77%

ROE

3.78%

P/VP

1.57

CI - Cigna

$ 289.48 --5,32% (12 M)

P/L

11.78

2.10%

ROE

15.39%

P/VP

1.81

CNC - Centene

$ 62.33 13,00% (12 M)

P/L

-4.76

0.00%

ROE

-29.93%

P/VP

1.42

HUM - Humana

$ 350.08 54,13% (12 M)

P/L

37.18

1.01%

ROE

6.06%

P/VP

2.25

SNY - Sanofi

$ 45.02 --3,18% (12 M)

P/L

7.36

8.84%

ROE

17.79%

P/VP

1.31

LLY - Eli Lilly

$ 1,131.42 47,32% (12 M)

P/L

39.95

0.55%

ROE

81.02%

P/VP

32.37

HCA - HCA Healthcare

$ 372.13 --2,35% (12 M)

P/L

12.27

0.79%

ROE

-228.14%

P/VP

-27.99

NVS - Novartis

$ 149.16 28,84% (12 M)

P/L

21.04

2.08%

ROE

34.77%

P/VP

7.31

Frequently Asked Questions

What is the price of Dr. Reddy's Laboratories (RDY) today?

The current price of Dr. Reddy's Laboratories (RDY) is $ 13.26, representing a -14.34% gain over the past year. The stock began the year trading around $ 14.04 and is currently priced at $ 13.26. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Dr. Reddy's Laboratories (RDY) pay dividends?

Dr. Reddy's Laboratories (RDY) did not pay dividends over the past year.

Is Dr. Reddy's Laboratories (RDY) a good investment?

Dr. Reddy's Laboratories (RDY) is currently trading at $ 13.26 with a P/E ratio of 22.75. This represents a 1,962% premium compared to its historical average P/E. Over the past year, the stock has gained -14.34 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.54%. The total shareholder return over the same period was -14.34%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Dr. Reddy's Laboratories (RDY) stock?

You can buy Dr. Reddy's Laboratories (RDY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RDY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Dr. Reddy's Laboratories (RDY) yield today?

Over the past month, Dr. Reddy's Laboratories (RDY) has returned -1.38% — -14.34% over the past year, and -5.32% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.07 per share in dividends, resulting in a dividend yield of 0.54%.

If you were to purchase 100 shares of Dr. Reddy's Laboratories (RDY) today at the current price of $ 13.26 your total investment would be $ 1,325.50.

Based on historical performance, the investment would have grown to approximately:

$ 1,135.42 after 1 year
$ 1,254.98 after 5 years
$ 2,048.43 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RDY

Dr. Reddy's Laboratories Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RDY

review the fundamentals of Dr. Reddy's Laboratories shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.54%

5-year average DY: 0.62%

type

Ex - Dividend Date

payment date

value

ABOUT Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd.

United States

42 years

2001

22.740

PROFIT X PRICE RDY

Financial Results RDY

RDY cash flow

Asset, Revenue and Profit Growth - RDY

RDY balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions